The high dose of Wegovy is one part of Novo Nordisk's plan to defend its obesity business, along with a major direct-to-consumer marketing drive for Wegovy and newer obesity candidates like CagriSema, which combines dual amylin and calcitonin receptor agonist cagrilintide with semaglutide, and dual GLP-1/amylin agonist amycretin
Metabolic irregularities can be checked by examining the profile of acylcarnitine in the blood
Metallic or altered taste sensations are occasionally reported, though less commonly than food aversions
Because your doctor works for your insurance company , getting an "off-formulary" (not on your plan's approved drug list) medication like Wegovy is harder than with other insurers
How long does it take for L Carnitine to work
Side effects are typically mild and temporary, with nausea being the most common during the early weeks of treatment as the body adjusts